VioQuest Pharmaceuticals, Inc.
VOQP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $4 | $1 |
| % Growth | – | -100% | 156.2% | – |
| Cost of Goods Sold | $0 | $0 | $2 | $1 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | – | – | 36.2% | 43.6% |
| R&D Expenses | $5 | $2 | $9 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4 | $3 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $5 | $14 | $5 |
| Operating Income | $10 | $5 | $13 | $4 |
| % Margin | – | – | 344.7% | 273.5% |
| Other Income/Exp. Net | -$2 | $0 | -$8 | -$0 |
| Pre-Tax Income | -$11 | $0 | -$13 | $0 |
| Tax Expense | -$0 | $3 | -$0 | -$0 |
| Net Income | -$11 | -$8 | -$13 | -$4 |
| % Margin | – | – | -337.3% | -270.9% |
| EPS | -2.33 | -2.08 | -5.82 | -2.35 |
| % Growth | -12% | 64.3% | -147.7% | – |
| EPS Diluted | -2.33 | -2.08 | -5.82 | -2.35 |
| Weighted Avg Shares Out | 5 | 4 | 2 | 2 |
| Weighted Avg Shares Out Dil | 5 | 4 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$7 | -$5 | -$10 | -$4 |
| % Margin | – | – | -272.1% | -241.5% |